Ultra-sensitive detection of rare T cell clones
Harlan Robins(Adaptive Biotechnologies (United States)), Karen Cerosaletti(Virginia Mason Medical Center), Cassian Yee(The University of Texas MD Anderson Cancer Center), Helena Reijonen(Virginia Mason Medical Center), Gerald T. Nepom(Virginia Mason Medical Center), Jessica Andriesen(Adaptive Biotechnologies (United States)), Jessica Matthis(Virginia Mason Medical Center), Christopher Carlson(Fred Hutch Cancer Center), Robert Livingston(Unknown), Cindy Desmarais(Adaptive Biotechnologies (United States))
Cited by 197
Related Papers
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
|New England Journal of Medicine|2008|903
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
|CHEST Journal|2000|632
Using synthetic templates to design an unbiased multiplex PCR assay
|Nature Communications|2013|607
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
|Cancer Immunology Research|2016|493